The health-care industry experienced a major boost as the largest health insurer, UnitedHealth, reported impressive second-quarter revenue growth, surpassing Wall Street expectations. This positive news led to a surge in UnitedHealth’s shares, rising more than 7%.
Eli Lilly Expands Portfolio Through Acquisition
In an effort to expand its portfolio, Eli Lilly announced its acquisition of Versanis Bio, a private company specializing in the development of obesity treatments. The acquisition deal is valued at up to $1.925 billion.
Lawsuit Filed by Johnson & Johnson Against Doctors
Johnson & Johnson has taken legal action against four doctors who published studies linking talc-based personal care products to cancer. The lawsuit aims to challenge the validity of these studies and their potential impact on the company.
Biotech Company Roivant Sciences in Negotiations for Billion-Dollar Drug Deal
Roivant Sciences, founded by Republican presidential candidate Vivek Ramaswamy, is currently engaged in discussions with Roche Holding to sell an experimental drug for a severe stomach disease. The potential deal, with a valuation exceeding $7 billion, highlights the significant growth of Roivant Sciences so far this year.
Canopy Growth Struggles Amid Debt Concerns
Canadian cannabis firm Canopy Growth faced challenges in the stock market following the disclosure of a debt refinancing plan. The company continues to be haunted by recent concerns about its financial stability.